Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors
published in: Clinical Cancer Research
date of publication: 2016-06-15
language: English
main subject: sirolimus
Cites articles 44
Date
Title
Article - wd:Q27853324